Benzinga Rankings give you vital metrics on any stock – anytime.
Explore SPDR Series Trust SPDR S&P Biotech ETF stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for XBI.
Open | - |
High | - |
52 Wk High | $105.47 |
AUM | 4.55B |
Dividend | $0.26 |
Ex-Div Date | Jun 24, 2024 |
Volume | - |
Market Cap | $24.66B |
Mgmt Fee | 0.35% |
P/E Ratio | 25.79 |
Prev. Close | $78.04 |
Low | - |
52 Wk Low | $66.66 |
Shares Out | 75.22M |
Yield | 0.27% |
Div. Freq | Quarterly |
Avg. Volume Daily | 8.45M |
Beta | 0.95 |
Avg. Expense Ratio | 0.35% |
P/B Ratio | 3.89 |
You can purchase shares of SPDR Series Trust SPDR S&P Biotech ETF (ARCA:XBI) through any online brokerage.
There are no as such competitors for SPDR Series Trust SPDR S&P Biotech ETF.
There is no analysis for SPDR Series Trust SPDR S&P Biotech ETF to provide a consensus price target.
The stock price for SPDR Series Trust SPDR S&P Biotech ETF (ARCA: XBI) is $78.2 last updated May 8, 2025 at 7:59 PM EDT.
A quarterly cash dividend of 0.07 per share of Class A Common Stock. The quarterly cash dividend was payable on September 26, 2018 to stockholders of record on September 21, 2018.
SPDR Series Trust SPDR S&P Biotech ETF does not have any upcoming earnings scheduled.
There is no upcoming split for SPDR Series Trust SPDR S&P Biotech ETF.
Open | - |
High | - |
52 Wk High | $105.47 |
AUM | 4.55B |
Dividend | $0.26 |
Ex-Div Date | Jun 24, 2024 |
Volume | - |
Market Cap | $24.66B |
Mgmt Fee | 0.35% |
P/E Ratio | 25.79 |
Prev. Close | $78.04 |
Low | - |
52 Wk Low | $66.66 |
Shares Out | 75.22M |
Yield | 0.27% |
Div. Freq | Quarterly |
Avg. Volume Daily | 8.45M |
Beta | 0.95 |
Avg. Expense Ratio | 0.35% |
P/B Ratio | 3.89 |
Sector | Healthcare |
Category | Mid Performer-Mid Growth |
Investment Style | Small Cap Growth |
Fund Inception | Jan 31, 2006 |
Managers | Raymond Donofrio Karl A. Schneider |
Definition | Most of the stocks in this equity fund have average financial performance and average growth potential |
Symbol | Name | Share % |
---|---|---|
NVAX | Novavax Inc | 3.06% |
INSM | Insmed Inc | 2.50% |
MRNA | Moderna Inc | 1.53% |
NTRA | Natera Inc | 2.66% |
DYN | Dyne Therapeutics Inc | 1.33% |
RVMD | Revolution Medicines I... | 1.32% |
PTCT | Ptc Therapeutics Inc | 1.29% |
BPMC | Blueprint Medicines Co... | 2.32% |
UTHR | United Therapeutics Co... | 2.43% |
AMGN | Amgen Inc. | 2.58% |
GILD | Gilead Sciences Inc | 2.54% |
ABBV | Abbvie Inc. | 2.32% |
BMRN | Biomarin Pharmaceutica... | 2.73% |
VRTX | Vertex Pharmaceuticals... | 2.56% |
INCY | Incyte Corp. | 2.33% |
ALNY | Alnylam Pharmaceutical... | 2.68% |
HALO | Halozyme Therapeutics ... | 2.37% |
BIIB | Biogen Inc. | 2.53% |
NBIX | Neurocrine Biosciences... | 2.49% |
EXAS | Exact Sciences Corp. | 2.59% |
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.